0 Bewertungen
ID

17245

Beschreibung

Zevalin-BEAM/BEAC With Autologous Stem Cell Support as Consolidation in First Line Treatment of Mantle Cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00514475

Link

https://clinicaltrials.gov/show/NCT00514475

Stichworte

Versionen (1)
  1. 01.09.16 01.09.16 -
Hochgeladen am

1. September 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

  • Neueste
  • Älteste
  • Beliebt
  • Neueste
    • Neueste
    • Älteste
    • Beliebt

    Keine Kommentare

    Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

    Eligibility Mantle Cell Lymphoma NCT00514475

    Englisch

    Eligibility Mantle Cell Lymphoma NCT00514475

    1 Formulare  
    Inclusion Criteria
    Beschreibung

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    1. age 18 - 65 years.
    Beschreibung

    Age

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0001779
    2. histologically confirmed (according to the who classification) mantle cell lymphoma stage ii-iv at time point of diagnosis. the diagnosis has to be confirmed by phenotypic expression of cd5, cd20 and cyclin-d1 and most cases will have t(11;14) translocation.
    Beschreibung

    Mantle cell lymphoma stage ii-iv, phenotypic expression of cd5, cd20 and cyclin-d1 and t(11;14) translocation in most cases

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0334634
    UMLS CUI [2]
    C1300072
    UMLS CUI [3]
    C3538992
    UMLS CUI [4]
    C3540684
    UMLS CUI [5]
    C0174680
    UMLS CUI [6]
    C1515705
    3. no previous treatment for lymphoma except radiotherapy or one cycle of any regimen and except patients treated in the previous phase ii study who can be transferred to nlg-mcl-iii before evaluation at week 15.
    Beschreibung

    no previous treatment for lymphoma except radiotherapy or one cycle of any regimen

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C1522449
    UMLS CUI [2,1]
    C1302181
    UMLS CUI [2,2]
    C0750480
    4. who performance status of 0 - 3.
    Beschreibung

    WHO performance status

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C1298650
    5. life expectancy of more than 3 months.
    Beschreibung

    Life expectancy

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0023671
    6. written informed consent.
    Beschreibung

    Informed consent

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0021430
    Exclusion Criteria
    Beschreibung

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    1. severe cardiac disease: cardiac function grade 3-4 (appendix 1).
    Beschreibung

    Cardiac function

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0232164
    2. impaired liver, renal or other organ function not caused by lymphoma, which will interfere with the treatment.
    Beschreibung

    Impaired liver, renal or other organ function

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0232741
    UMLS CUI [2]
    C0232804
    UMLS CUI [3]
    C0232164
    UMLS CUI [4,1]
    C1321605
    UMLS CUI [4,2]
    C0439801
    UMLS CUI [4,3]
    C0009488
    3. pregnancy/lactation
    Beschreibung

    Pregnancy/lactation

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0032961
    UMLS CUI [2]
    C0006147
    4. men or woman of reproductive potential not agreeing to use acceptable method of birth control during treatment and for six moths after completion of treatment.
    Beschreibung

    Contraceptive methods

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0700589
    5. known hiv positivity
    Beschreibung

    HIV

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0019699
    6. any other prior malignancy than non-melanoma skin cancer or stage 0 (in situ) cervical carcinoma.
    Beschreibung

    Malignancy

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0006826
    7. known seropositivity for hcv, hbsag or other active infection uncontrolled by treatment.
    Beschreibung

    Seropositivity for hcv, hbsag or other active infection

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0019196
    UMLS CUI [2]
    C0019168
    UMLS CUI [3]
    C0009450
    8. psychiatric illness or condition which could interfere with their ability to understand the requirements of the study.
    Beschreibung

    psychiatric illness

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C1321605
    UMLS CUI [1,2]
    C0439801
    UMLS CUI [1,3]
    C0004936
    Zum Seitenanfang zurückkehren

    Ähnliche Modelle

    Eligibility Mantle Cell Lymphoma NCT00514475

    1 Formulare
    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datentyp
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Age
    Item
    1. age 18 - 65 years.
    boolean
    C0001779 (UMLS CUI [1])
    Mantle cell lymphoma stage ii-iv, phenotypic expression of cd5, cd20 and cyclin-d1 and t(11;14) translocation in most cases
    Item
    2. histologically confirmed (according to the who classification) mantle cell lymphoma stage ii-iv at time point of diagnosis. the diagnosis has to be confirmed by phenotypic expression of cd5, cd20 and cyclin-d1 and most cases will have t(11;14) translocation.
    boolean
    C0334634 (UMLS CUI [1])
    C1300072 (UMLS CUI [2])
    C3538992 (UMLS CUI [3])
    C3540684 (UMLS CUI [4])
    C0174680 (UMLS CUI [5])
    C1515705 (UMLS CUI [6])
    no previous treatment for lymphoma except radiotherapy or one cycle of any regimen
    Item
    3. no previous treatment for lymphoma except radiotherapy or one cycle of any regimen and except patients treated in the previous phase ii study who can be transferred to nlg-mcl-iii before evaluation at week 15.
    boolean
    C1522449 (UMLS CUI [1])
    C1302181 (UMLS CUI [2,1])
    C0750480 (UMLS CUI [2,2])
    WHO performance status
    Item
    4. who performance status of 0 - 3.
    boolean
    C1298650 (UMLS CUI [1])
    Life expectancy
    Item
    5. life expectancy of more than 3 months.
    boolean
    C0023671 (UMLS CUI [1])
    Informed consent
    Item
    6. written informed consent.
    boolean
    C0021430 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    Cardiac function
    Item
    1. severe cardiac disease: cardiac function grade 3-4 (appendix 1).
    boolean
    C0232164 (UMLS CUI [1])
    Impaired liver, renal or other organ function
    Item
    2. impaired liver, renal or other organ function not caused by lymphoma, which will interfere with the treatment.
    boolean
    C0232741 (UMLS CUI [1])
    C0232804 (UMLS CUI [2])
    C0232164 (UMLS CUI [3])
    C1321605 (UMLS CUI [4,1])
    C0439801 (UMLS CUI [4,2])
    C0009488 (UMLS CUI [4,3])
    Pregnancy/lactation
    Item
    3. pregnancy/lactation
    boolean
    C0032961 (UMLS CUI [1])
    C0006147 (UMLS CUI [2])
    Contraceptive methods
    Item
    4. men or woman of reproductive potential not agreeing to use acceptable method of birth control during treatment and for six moths after completion of treatment.
    boolean
    C0700589 (UMLS CUI [1])
    HIV
    Item
    5. known hiv positivity
    boolean
    C0019699 (UMLS CUI [1])
    Malignancy
    Item
    6. any other prior malignancy than non-melanoma skin cancer or stage 0 (in situ) cervical carcinoma.
    boolean
    C0006826 (UMLS CUI [1])
    Seropositivity for hcv, hbsag or other active infection
    Item
    7. known seropositivity for hcv, hbsag or other active infection uncontrolled by treatment.
    boolean
    C0019196 (UMLS CUI [1])
    C0019168 (UMLS CUI [2])
    C0009450 (UMLS CUI [3])
    psychiatric illness
    Item
    8. psychiatric illness or condition which could interfere with their ability to understand the requirements of the study.
    boolean
    C1321605 (UMLS CUI [1,1])
    C0439801 (UMLS CUI [1,2])
    C0004936 (UMLS CUI [1,3])
    Zum Seitenanfang zurückkehren 

    Hilfe

    Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

    Zum Video